Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. OTC
  4. SOMNF

Market Cap: $52.51M

SL

SomnoMed Limited

SOMNF
OTC (Other OTC)USD
Purchase SOMNF
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin54.48%
EBITDA Margin5.64%
EBIT Margin0.85%
Pre-tax Margin-0.40%
Net Profit Margin-2.31%
Earnings Yield-3.66%
Valuation Multiples
Price / Book1.53
Price / Sales0.63
Price / Earnings-27.27
PEG-1.01
Forward PEG-0.54
EV / Sales0.53
EV / EBITDA9.41
EV / Operating Cash Flow7.34
EV / Free Cash Flow12.12
Price / Free Cash Flow14.46
Price / Operating Cash Flow8.74
Cash Flow & Capital
Free Cash Flow / Share$0.02
Operating Cash Flow / Share$0.04
Free Cash Flow Yield6.92%
Capex / Revenue2.85%
Capex / Operating Cash Flow39.39%
Capex / Depreciation0.59
Stock Compensation / Revenue0.00%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio1.67
Quick Ratio1.36
Cash Ratio0.74
Debt / Assets0.07
Debt / Capital0.10
Debt / Equity0.12
Long-Term Debt / Capital0.01
Debt / Market Cap3.53%
Net Debt / EBITDA-1.81
Solvency Ratio0.10
Financial Leverage1.58
Efficiency & Working Capital
Asset Turnover1.53
Fixed Asset Turnover9.29
Inventory Turnover7.09
Receivables Turnover9.85
Payables Turnover8.67
Days Sales Outstanding37.05
Days Inventory Outstanding51.5
Days Payables Outstanding42.09
Operating Cycle88.56
Cash Conversion Cycle46.46
Working Capital Turnover6.62
Returns & Quality
Return on Equity-5.44%
Return on Assets-3.53%
Return on Invested Capital1.81%
ROCE1.89%
Return on Tangible Assets-5.04%
Operating Return on Assets1.26%
Income Quality-3.12
Tax Burden5.79
Interest Burden-0.47
Balance Sheet & Intrinsic Metrics
Enterprise Value$60.8M
Invested Capital$50.37M
Working Capital$15.68M
Tangible Asset Value$25.03M
Net Current Asset Value$11.35M
Graham Net-Net$0.01
Book Value / Share$0.22
Tangible Book Value / Share$0.11
Cash / Share$0.08
Financial Health Scores
Piotroski Score5
Altman Z-Score4.80
Revenue$225.93M
EBIT$666.45K
Market Cap$138.08M
Working Capital$15.66M
Retained Earnings$-80.53M
Total Assets$74.89M
Total Liabilities$27.56M